SMD Rise PCL's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 119.89.
SMD Rise PCL's Days Inventory for the
three
months ended in Mar. 2026 was 348.26.
SMD Rise PCL's Days Payable for the
three
months ended in Mar. 2026 was 205.92.
Therefore, SMD Rise PCL's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 262.23.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
SMD Rise PCL Cash Conversion Cycle Related Terms
SMD Rise PCL Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, COR, CAH: Cash Conversion Cycle Comparison
For the Medical Distribution subindustry, SMD Rise PCL's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Cash Conversion Cycle vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
SMD Rise PCL's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL (BKK:SMD100-R) has a Cash Conversion Cycle of 262.23 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on SMD Rise PCL and its competitors.
Is SMD Rise PCL's Cash Conversion Cycle too high?
SMD Rise PCL's current Cash Conversion Cycle is 262.23. The Medical Distribution industry median Cash Conversion Cycle is 56.66. SMD Rise PCL's value of 262.23 is 362.8% above this industry median. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Cash Conversion Cycle compare to MCK and COR?
SMD Rise PCL's Cash Conversion Cycle of 262.23 can be compared against companies in the Medical Distribution industry. The industry median Cash Conversion Cycle is 56.66. SMD Rise PCL's value of 262.23 is 362.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Distribution company?
The median Cash Conversion Cycle among Medical Distribution companies is 56.66, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current Cash Conversion Cycle of 262.23 is 362.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Cash Conversion Cycle is 56.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Cash Conversion Cycle is 262.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Cash Conversion Cycle of 262.23. The stock's GF Value™ is ฿23.66, compared to a current price of ฿5.85 — trading 75.3% below its estimated fair value. The current Cash Conversion Cycle is 262.23 and 362.8% above the Medical Distribution industry median of 56.66. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Cash Conversion Cycle is 262.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 75.3% below its estimated GF Value™ of ฿23.66.
Key valuation signals for BKK:SMD100-R:
Cash Conversion Cycle: 262.23
GF Value™: ฿23.66 vs. price of ฿5.85 (75.3% below fair value)
Industry Position: 362.8% above the Medical Distribution median
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
